Company News

Merz Pharma Group Acquires Swiss Derm Company Neocutis S.A.

Author Image

By: TOM BRANNA

Editor

Merz Pharma Group has entered into a definitive agreement with Swiss dermatology company Neocutis to acquire the privately held company’s cosmetics, OTC and Rx skin care business, which includes Neocutis, a line of physician-dispensed topical skin care products sold in the US. “Neocutis is an innovative company with an excellent presence in the US market, and a promising potential for development,” said Philip Burchard, CEO of Merz Pharma Group. “This transaction is an important step to expand ...

Continue reading this story and get 24/7 access to Happi for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Happi Newsletters